Skip to content

Frontiers in Psychiatry

ISSN 1664-0640

601 papers in the library · 9,228 citations · publishing 2010-2026

Papers

Sort Most recent Most cited

Behavioural, Pharmacokinetic, Metabolic, and Hyperthermic Profile of 3,4-Methylenedioxypyrovalerone (MDPV) in the Wistar Rat

Frontiers in Psychiatry April 24, 2018 Rachel R. Horsley, Eva Lhotková, Kateřina Hájková et al. 20 citations

3,4-methylenedioxypyrovalerone (MDPV) is a potent pyrovalerone cathinone that is substituted for amphetamines by recreational users. We report a comprehensive and detailed description of the effects of subcutaneous MDPV (1-4 mg/kg) on pharmacokinetics, biodistribution and metabolism, acute effects on thermoregulation under isolated and aggregated conditions, locomotion (open field) and sensory...

DOI: 10.3389/fpsyt.2018.00144 (opens in new tab) Pharmacokinetics Pharmacology Thermoregulation Cathinone +6

Mindfulness-Based Interventions for the Treatment of Substance and Behavioral Addictions: A Systematic Review

Frontiers in Psychiatry March 29, 2018 Marta Sancho, Marta de Gracia, Rita Cristina Rodríguez et al. 229 citations

BACKGROUND: Emotion (dys)regulation as well as the interventions for improving these difficulties are receiving a growing attention in the literature. The aim of the present paper was to conduct a systematic review about the efficacy of mindfulness-based interventions (MBIs) in both substance and behavioral addictions (BAs). METHOD: A literature search was conducted using Cochrane, PubMed, and...

Non-Dependent and Dependent Daily Cannabis Users Differ in Mental Health but Not Prospective Memory Ability

Frontiers in Psychiatry March 27, 2018 Ruth Braidwood, Samantha Mansell, Jon Waldron et al. 7 citations

Research suggests that daily cannabis users have impaired memory for past events, but it is not clear whether they are also impaired in prospective memory (PM) for future events. The present study examined prospective memory in daily cannabis users who were either dependent (n = 18) or non-dependent (n = 18), and compared them with non-using controls (n = 18). The effect of future event...

Self-Reported Visual Perceptual Abnormalities Are Strongly Associated with Core Clinical Features in Psychotic Disorders

Frontiers in Psychiatry March 12, 2018 Brian Patrick Keane, Lisa N. Cruz, Danielle Paterno et al. 57 citations

BACKGROUND: perceptual abnormalities (VPAs) since they are underexplored and have been associated with suicidal ideation, negative symptoms, and objective visual dysfunction. METHOD: Using the 17 Bonn Scale vision items, we cross-sectionally investigated lifetime occurrence of VPAs in 21 first-episode psychosis and 22 chronic schizophrenia/schizoaffective disorder (SZ/SA) patients....

Repeated Exposure to the “Spice” Cannabinoid JWH-018 Induces Tolerance and Enhances Responsiveness to 5-HT1A Receptor Stimulation in Male Rats

Frontiers in Psychiatry February 27, 2018 Joshua S. Elmore, Michael H. Baumann 26 citations

Naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) is a synthetic compound found in psychoactive “spice” products that activates cannabinoid receptors. Preclinical evidence suggests that exposure to synthetic cannabinoids increases 5-HT2A/2C receptor function in the brain, an effect which might contribute to psychotic symptoms. Here, we hypothesized that repeated exposures to JWH-018 would...

DOI: 10.3389/fpsyt.2018.00055 (opens in new tab) Serotonin Catalepsy 5-ht1a receptor Hypothermia +9

No Laughing Matter: Presence, Consumption Trends, Drug Awareness, and Perceptions of “Hippy Crack” (Nitrous Oxide) among Young Adults in England

Frontiers in Psychiatry January 22, 2018 Esther M. Ehirim, D. Naughton, A. Petróczi

In clinical settings, nitrous oxide gas is a safe anesthetic used during childbirth, in dentistry, and to relieve anxiety in emergencies. Colloquially known as “hippy crack”’ or “laughing gas,” it is increasingly taken recreationally for its euphoric and relaxing effects and hallucinogenic properties. Using a self-reported survey, we gathered quantitative and qualitative information on users...

Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats

Frontiers in Psychiatry January 10, 2018 Klára Šíchová, Nikola Pinterová, Monika Židková et al. 28 citations

Mephedrone (MEPH) is a synthetic cathinone derivative with effects that mimic MDMA and/or cocaine. Our study in male Wistar rats provides detailed investigations of MEPH's and its primary metabolite nor-mephedrone's (nor-MEPH) pharmacokinetics and bio-distribution to four different substrates (serum, brain, lungs, and liver), as well as comparative analysis of their effects on locomotion [open...

DOI: 10.3389/fpsyt.2017.00306 (opens in new tab) Pharmacology Mephedrone Pharmacokinetics Drug

Phobia of the Supernatural: A Distinct but Poorly Recognized Specific Phobia With an Adverse Impact on Daily Living.

Frontiers in Psychiatry 2018 Ricardo de Oliveira‐souza

The psychological and psychiatric literature has seldom appreciated the clinical fact that fears of ghosts and kindred supernatural worries may be a cause of intense discomfort, poor sleep, and socio-occupational impairment. In the present article, this claim is illustrated by the clinical features of six patients who developed intense anxiety when they had to sleep alone at night. The fears...

From Default Mode Network to the Basal Configuration: Sex Differences in the Resting-State Brain Connectivity as a Function of Age and Their Clinical Correlates.

Frontiers in Psychiatry 2018 Sean D Conrin, Liang Zhan, Zachery D Morrissey et al.

Connectomics is a framework that models brain structure and function interconnectivity as a network, rather than narrowly focusing on select regions-of-interest. MRI-derived connectomes can be structural, usually based on diffusion-weighted MR imaging, or functional, usually formed by examining fMRI blood-oxygen-level-dependent (BOLD) signal correlations. Recently, we developed a novel method...

DOI: 10.3389/fpsyt.2018.00365 (opens in new tab) Full text (opens in new tab) Default-mode network Brain connectivity Community structure Human connectome project +3

Reliving, Replaying Lived Experiences Through Auditory Verbal Hallucinations: Implications on Theories and Management.

Frontiers in Psychiatry 2018 Smriti Vallath, Tanya M Luhrmann, Joske Bunders et al.

Objective: This study aims to understand the impact of negative life experience (NLE) in auditory hallucinations (AHs) and explain the heterogeneity in phenomenology of auditory verbal hallucinations (AVHs). Method: In depth interviews were conducted with 21 individuals (7 males and 14 females) experiencing AHs and accessing mental health treatment services at a not-for-profit organization....

DOI: 10.3389/fpsyt.2018.00528 (opens in new tab) Full text (opens in new tab) Phenomenology Auditory verbal hallucinations Lived experiences Treatment strategies +1

Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies.

Frontiers in Psychiatry 2018 Cheng-Ta Li, Kai‐Chun Yang, Wei-Chen Lin

Excessive glutamate release has been linked to stress and many neurodegenerative diseases. Evidence indicates abnormalities of glutamatergic neurotransmission or glutamatergic dysfunction as playing an important role in the development of many major psychiatric disorders (e.g., schizophrenia, bipolar disorder, and major depressive disorder). Recently, ketamine, an N-methyl-d-aspartate...

DOI: 10.3389/fpsyt.2018.00767 (opens in new tab) Full text (opens in new tab) Nmda antagonist Antidepressant Glutamate Major psychiatric disorders +1

Seeing Beyond Diseases and Disorders: Symptom Complexes as Manifestations of Mental Constituents.

Frontiers in Psychiatry 2018 Maurício V Daker

Many psychopathologists have approached symptom complexes without prejudging them as physical deficits or diseases, an approach suitable to connections with normal mind, to a broad dimensional and anthropological view of mental disorders. It contrasts with the prevailing orientation in psychiatry toward the medical model of delimited diseases. Discussions of this order centered on symptom...

DOI: 10.3389/fpsyt.2018.00681 (opens in new tab) Full text (opens in new tab) Dimensional diagnosis History of psychiatry Personality Philosophy and psychiatry +4

The Factorial Structure of Trait Anxiety and Its Mediating Effect Between Mindfulness and Depression.

Frontiers in Psychiatry 2018 Tao Wang, Min Li, Song Xu et al.

Background: Increasing studies have found that high trait anxiety is a key susceptibility phenotype that causes depression. Mindfulness-based interventions can target on dealing with depressogenic vulnerability effectively. Evidence indicates that trait anxiety could affect the trajectory of anti-depressive psychotherapy, and play an important role in the relationship between mindfulness and...

DOI: 10.3389/fpsyt.2018.00514 (opens in new tab) Full text (opens in new tab) Depression Mindfulness-based cognitive therapy Personality Trait anxiety

Methylation of FKBP5 and SLC6A4 in Relation to Treatment Response to Mindfulness Based Stress Reduction for Posttraumatic Stress Disorder.

Frontiers in Psychiatry 2018 Jeffrey R Bishop, Adam M Lee, Lauren J Mills et al.

Mindfulness Based Stress Reduction (MBSR) is an effective non-pharmacologic treatment for veterans with PTSD. Extensive work has identified epigenetic factors related to PTSD disease risk and pathophysiology, but how these factors influence treatment response is unclear. Serotonin signaling and hypothalamic-pituitary-adrenal (HPA) axis functioning may be perturbed in PTSD and are molecular...

Auditory Verbal Hallucinations in Borderline Personality Disorder and the Efficacy of Antipsychotics: A Systematic Review.

Frontiers in Psychiatry 2018 Christina W. Slotema, Jan Dirk Blom, Marieke B A Niemantsverdriet et al.

Background: Auditory verbal hallucinations (AVH) are experienced more frequently by patients with borderline personality disorder (BPD) than previously assumed. However, consensus is lacking on how to treat them. Objective: To provide a systematic review of studies reporting on AVH in patients with BPD, with a focus on the efficacy of treatment of psychotic symptoms. Methods: For this review a...

Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review.

Frontiers in Psychiatry 2018 Jennifer L Jones, Camilo F Mateus, Robert J Malcolm et al.

Background: Despite advances in behavioral and pharmacotherapy interventions, substance use disorders (SUDs) are frequently refractory to treatment. Glutamatergic dysregulation has received increasing attention as one common neuropathology across multiple substances of abuse. Ketamine is a potent N-methyl-D-aspartate (NMDA) glutamatergic receptor antagonist which has been found to be effective...

Self-Regulation of Breathing as an Adjunctive Treatment of Insomnia.

Frontiers in Psychiatry 2018 Ravinder Jerath, Connor Beveridge, Vernon A Barnes

Sleep is a quiescent behavioral state during which complex homeostatic functions essential to health and well-being occur. Insomnia is a very common psychiatric disorder leading to a myriad of detrimental effects including loss of concentration, memory, and performance as well as disease. Current pharmaceutical treatments can be expensive, impairing, unhealthy, and habit-forming. Relaxation...

DOI: 10.3389/fpsyt.2018.00780 (opens in new tab) Full text (opens in new tab) Autonomic nervous system Cardiorespiratory synchronization Evolutionary mismatch hypothesis Hyper-arousal +3

Decreased Blood Levels of Oxytocin in Ketamine-Dependent Patients During Early Abstinence.

Frontiers in Psychiatry 2018 Ming-Chyi Huang, Lian-Yu Chen, Hu-Ming Chang et al.

Background: Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is a common drug of abuse worldwide. Existing evidence suggest a disruption of oxytocin system involves in the development of addiction. In this study, we aimed to investigate the role of oxytocin in ketamine addiction by measuring the blood oxytocin levels in ketamine-dependent (KD) patients. Methods: Sixty-five KD...

Prevalence Rates of the Incubus Phenomenon: A Systematic Review and Meta-Analysis

Frontiers in Psychiatry November 23, 2017 Marc L. Molendijk, Harriët Montagne, Ouarda Bouachmir et al. 19 citations

Background: The incubus phenomenon is a paroxysmal sleep-related disorder characterized by compound hallucinations experienced during brief phases of (apparent) wakefulness. The condition has an almost stereotypical presentation, characterized by a hallucinated being that exerts pressure on the thorax, meanwhile carrying out aggressive and/or sexual acts. It tends to be accompanied by sleep...

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review

Frontiers in Psychiatry November 20, 2017 Laura Orsolini, Gabriele Duccio Papanti, Domenico de Berardis et al. 99 citations

Hallucinogen-persisting perception disorder (HPPD) is a syndrome characterized by prolonged or reoccurring perceptual symptoms, reminiscent of acute hallucinogen effects. HPPD was associated with a broader range of LSD (lysergic acid diethylamide)-like substances, cannabis, methylenedioxymethamphetamine (MDMA), psilocybin, mescaline, and psychostimulants. The recent emergence of novel...

Pharmacokinetic, Ambulatory, and Hyperthermic Effects of 3,4-Methylenedioxy-N-Methylcathinone (Methylone) in Rats

Frontiers in Psychiatry November 17, 2017 Kristýna Štefková, Monika Židková, Rachel R. Horsley et al. 82 citations

-methylcathinone) is a synthetic cathinone analog of the recreational drug ecstasy. Although it is marketed to recreational users as relatively safe, fatalities due to hyperthermia, serotonin syndrome, and multi-organ system failure have been reported. Since psychopharmacological data remain scarce, we have focused our research on pharmacokinetics, and on a detailed evaluation of temporal...

DOI: 10.3389/fpsyt.2017.00232 (opens in new tab) Pharmacology Cathinone Mephedrone Pharmacokinetics +3

Synthetic Aminoindanes: A Summary of Existing Knowledge

Frontiers in Psychiatry November 17, 2017 Nikola Pinterová, Rachel R. Horsley, Tomáš Páleníček 37 citations

Objectives: Aminoindanes (“bath salts”, a class of novel psychoactive substances, NPSs) increased rapidly in popularity on the recreational drug market, particularly after mephedrone and other synthetic cathinones were banned in the UK in 2010. Novel aminoindanes continue to emerge, but relatively little is known about their effects and risks. Their history, chemistry, pharmacology, behavioural...

A Pilot Study of the Effects of Mindfulness-Based Stress Reduction on Post-traumatic Stress Disorder Symptoms and Brain Response to Traumatic Reminders of Combat in Operation Enduring Freedom/Operation Iraqi Freedom Combat Veterans with Post-traumatic Stress Disorder

Frontiers in Psychiatry August 25, 2017 J. Douglas Bremner, Sanskriti Mishra, Carolina Campanella et al. 81 citations

OBJECTIVE: Brain imaging studies in patients with post-traumatic stress disorder (PTSD) have implicated a circuitry of brain regions including the medial prefrontal cortex, amygdala, hippocampus, parietal cortex, and insula. Pharmacological treatment studies have shown a reversal of medial prefrontal deficits in response to traumatic reminders. Mindfulness-based stress reduction (MBSR) is a...

DOI: 10.3389/fpsyt.2017.00157 (opens in new tab) Traumatic stress Anxiety Mindfulness-based stress reduction Prefrontal cortex +3

Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs

Frontiers in Psychiatry August 18, 2017 Zurina Hassan, Oliver G. Bosch, Darshan Singh et al. 62 citations

A feature of human culture is that we can learn to consume chemical compounds, derived from natural plants or synthetic fabrication, for their psychoactive effects. These drugs change the mental state and/or the behavioral performance of an individual and can be instrumentalized for various purposes. After the emergence of a novel psychoactive substance (NPS) and a period of experimental...

DOI: 10.3389/fpsyt.2017.00152 (opens in new tab) Psychotropic drugs Mind-altering substances Novel compounds Medical benefits +6

The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish

Frontiers in Psychiatry August 13, 2017 Luisa Ponzoni, Daniela Braida, Gianpietro Bondiolotti et al. 9 citations

3,4-methylenedioxymethamphetamine (MDMA) and its derivatives, 2,5-dimethoxy-4-bromo-amphetamine hydrobromide (DOB) and para-methoxyamphetamine (PMA) are recreational drugs whose pharmacological effects have recently been attributed to serotonin 5HT2A/C receptors. However, there is growing evidence that the oxytocin/vasopressin system can modulate some the effects of MDMA. In this study, MDMA...